PODD · 8-K · 20260805PR000167
Operating Income and Margins
INSULET CORP · 2026-08-05 · Importance 57 · Surprise 50 · No source text
Second-quarter GAAP operating income increased to $129.7 million from $121.1 million, but GAAP operating margin declined 250 basis points to 16.2% of revenue. The margin comparison included $25.0 million of voluntary medical device correction and related costs, including the $21.9 million gross-profit charge. Adjusted operating income rose to $154.5 million, and adjusted operating margin expanded more than 140 basis points to 19.3%. Six-month GAAP operating income was $251.8 million, or 16.1% of revenue, compared with $209.9 million, or 17.2%, in 2025.
Key facts
- Operating income for the quarter: $129.7 million, or 16.2% of revenue, down 250 basis points versus prior year. source
- Adjusted operating income for the quarter: $154.5 million, or 19.3% of revenue, up over 140 basis points versus prior year. source
- Guidance: Adjusted operating margin expected to expand approximately 100 basis points year-over-year for Q3 2026 and FY 2026. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| margin | negative | realized | -2.5% | Operating income for the quarter: $129.7 million, or 16.2% of revenue, down 250 basis points versus prior year. |
| margin | positive | realized | +1.4% | Adjusted operating income for the quarter: $154.5 million, or 19.3% of revenue, up over 140 basis points versus prior year. |
| margin | positive | committed | +0.8% | Guidance: Adjusted operating margin expected to expand approximately 100 basis points year-over-year for Q3 2026 and FY 2026. |
| operating_income | negative | realized | — | Operating income for the quarter: $129.7 million, or 16.2% of revenue, down 250 basis points versus prior year. |
| operating_income | positive | realized | — | Adjusted operating income for the quarter: $154.5 million, or 19.3% of revenue, up over 140 basis points versus prior year. |